Published in Hepatitis Weekly, June 24th, 2002
Based on a retrospective analysis of outcomes in the recipients of such livers, and contrary to common practice, researchers at Loyola University - Chicago, which is located in Chicago, Illinois, have proposed that using HBcAb positive liver grafts is okay, as long as certain therapies are also prescribed for the patient.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.